300519.SZ
新光药业
SZSE · Healthcare · C 制造业 · CN
CNY 14.08
−1.47%Margins
Gross margin
41.7%
EBITDA margin
30.5%
EBIT margin
25.9%
Net margin
21.5%
FCF margin
29.2%
6.5%
Return on equity
6.1%
Return on assets
7.8%
Return on invested capital
0.29x
Asset turnover
CNY 78.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026